Detalhe da pesquisa
1.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med
; 372(26): 2509-20, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028255
2.
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Int J Cancer
; 136(1): 127-37, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832153
3.
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.
Ann Surg Oncol
; 21(12): 3931-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24943235
4.
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.
J Immunol
; 186(7): 3847-57, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21346233
5.
A ubiquitin-proteasome pathway represses the Drosophila immune deficiency signaling cascade.
Curr Biol
; 12(20): 1728-37, 2002 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12401167
6.
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
J Clin Oncol
; 33(12): 1325-33, 2015 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584002
7.
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.
Cancer Immunol Res
; 2(10): 949-61, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25116755
8.
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.
J Immunother
; 36(7): 382-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23924790
9.
Current advances in immunotherapy for pancreatic cancer.
Curr Probl Cancer
; 37(5): 273-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24331182